Titre:
  • Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab
Auteur:Debien, Véronique; Marta, Guilherme Nader; Agostinetto, Elisa; Sirico, Marianna; Jacobs, Flavia; Molinelli, Chiara; Moreau, Michel; Paesmans, Marianne; De Giorgi, Ugo; Santoro, Armando; Taylor, Donatienne; Duhoux, Francois F.P.; Botticelli, Andrea; Barchiesi, Giacomo; Speranza, Iolanda; Lambertini, Matteo Md Phd M.; Wildiers, Hans; de Azambuja, Evandro; Piccart-Gebhart, Martine
Informations sur la publication:Critical reviews in oncology/hematology, 190, 104089
Statut de publication:Publié, 2023-10-01
Sujet CREF:Gériatrie - gérontologie
Hématologie
Cancérologie
Mots-clés:Adjuvant
De-escalation
HER2-positive breast cancer
Real-world data
Stage I
Trastuzumab
Treatment optimization
Note générale:SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1040-8428
info:doi/10.1016/j.critrevonc.2023.104089
info:pii/S1040842823001774
info:scp/85168013890
info:pmid/37562696